116856-18-9,
2-(5-Formamido-1H-pyrazol-1-yl)ethyl formate,
5-Formamide-1-(2-formyloxyethl)pyrazole,
5-Formamido-1-[2-(formyloxy)ethyl]pyrazole,
5-formamido-1-(2-formyloxyethyl)pyrazole,
5-Formylamino-1-(2-formyloxyethyl)pyrazole,
MFCD09744040,
AK-87685,
PubChem15369,
2-(5-formamidopyrazol-1-yl)ethyl formate,
SCHEMBL8881436,
TPC-I141,
N-[1-[2-(Formyloxy)ethyl]-1H-pyrazol-5-yl]formamide,
CTK8B4621,
DTXSID00566712,
ADNBFDFIEWMUBJ-UHFFFAOYSA-N,
BCP22688,
KS-00000F5Q,
ANW-45701,
ZINC34425128,
AKOS006332048,
AC-8291,
AN-8165,
CF-1050,
RP24394,
5-formamido-l-(2-formyloxyethyl)pyrazole,
AJ-88472,
DS-18358,
OR315032,
S497,
SC-28070,
SY033895,
5-formamido-1-(2-formyloxyethyl) pyrazole,
AX8104117,
DB-019085,
TC-134446,
2-(5-formamidopyrazol-1-yl)ethyl methanoate,
F0890,
FT-0657075,
ST24032343,
MFCD09744040 (97%),
856F189,
A803686,
formic acid 2-(5-formamido-1-pyrazolyl)ethyl ester,
I11-0023,
J-517564,
Formamide, N-[1-[2-(formyloxy)ethyl]-1H-pyrazol-5-yl]-,
C7H9N3O3,
ACN-034414,
5-formamide-1-(2-formyloxyethyl)pyrazole,
Cefozopran side Chain: Imidazo-[1,2-b]pyridazine,